Prof. Eyal Mishani | Hadassah International

Hadassah International Supports the Hadassah Medical Center: More than a Hospital!

Hadassah’s Organoid Bio-Bank Promises Patients Personalized Medicine

Several years ago, Prof. Eyal Mishani, director of HMO’s Research Fund and the head of the Research and Development and Innovation Division started the work to bring organoid technology developed…

Hadassah Hospital

Organoids Help Personalize Treatment for Cancer Patients at Hadassah

Hadassah Hospital

Hyperdriving Research

...More than a Hospital

Hadassah Physician-Scientists Are Showcased at Global Press Conference

COVID-19: Can We Win the War?

On the Way to a Cure for COVID-19: Hadassah’s Researchers Forge Ahead

...More than a Hospital

Critical Medical Research on COVID-19 at Hadassah is Shared with an International Audience

...More than a Hospital

COVID-19 On The Way to a Cure – Special Zoom Webinar with Prof. Eyal Mishani

...More than a Hospital

Hadassah Begins New Clinical Drug Trial for COVID-19 Patients

Alzheimer’s Further Illuminated at Hadassah with New Exclusive Imaging Agent

Hadassah Firsts

Hadassah is First Israeli Hospital to Join Global Research Network

Head of Hadassah’s R & D Invited to Thailand for Royal Celebration and Conference

Hadassah Participates in Worldwide Breakthrough of Genetic Links to Diabetes

Research in Service to Humanity: Hadassah’s DNA

Cardiology Research

Hadassah-Developed Imaging Agent to Begin Clinical Trials with Multi-million Euro Grant